Free Review Articles on Alzheimer disease                                 Metatextbook

Freie Reviews über Alzheimer Erkrankung                                 Look here for Journal Homepages

  • Alzheimer disease
  • Rivastigmin
  • Memantine
  • History of medicine
  • Septum (Neurophysiology)
  • Sirtuin
  • Structure determination between tissue level and single molecule localization and molecular imaging
  • Maillard reaction
  • Donepezil
  • Galantamine
  • BACE1
  • Amyloid angiopathy
  • Nervous system (Neurodegeneration)
  • Lewy body
  • Synuclein
  • Amyotrophic lateral sclerosis
  • TDP43
  • Frontotemporal lobar degeneration
  • Amyloid precursor protein
  • Niemann Pick s disease C
  • Biomembranes
  • Neuron (BASKET)
  • Lipid rafts and membrane microdomains
  • Mitochondrium (BASKET)
  • Parkinson s disease
  • Lipid peroxide
  • Pin1
  • Apolipoprotein E4
  • Dementia (frontotemporal)
  • gamma Secretase
  • Cystatin
  • Retinoids
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12005Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.



    		+-nlBMJ 331(7512):321-7 (2005) Kaduszkiewicz H
    22005Treatments for Alzheimer disease.



    		+-nlSouth Med J 98(6):628-35 (2005) Potyk D
    32001Biological and genetic markers of sporadic Alzheimer's disease.



    		+-nlActa Med Okayama 55(2):55-63 (2001)
    42009Mitochondrial Drugs for Alzheimer Disease.



    		+-nlPharmaceuticals (Basel) 2(3):287-298 (2009) Bonda DJ
    51999Diagnosis, management, and treatment of Alzheimer disease: a guide for the internist.



    		+-nlArch Intern Med 159(8):789-98 (1999)
    61997The genetics and pathophysiology of Alzheimer's disease.



    		+-nlJ Intern Med 242(4):281-4 (1997)
    72009Alzheimer disease: time to improve its diagnosis and treatment.



    		+-nlCleve Clin J Med 76(1):49-58 (2009) Salloway S
    82008Insular Alzheimer disease pathology and the psychometric correlates of mortality.



    		+-nlCleve Clin J Med 75 Suppl 2():S97-9 (2008) Royall DR
    92008Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.



    		+-nlClin Interv Aging 3(2):211-25 (2008) Hansen RA
    102007Pathogenesis of Alzheimer's disease.



    		+-nlClin Interv Aging 2(3):347-59 (2007) Swerdlow RH
    112007Rivastigmine in the treatment of Alzheimer's disease: an update.



    		+-nlClin Interv Aging 2(1):17-32 (2007) Onor ML
    122007Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease.



    		+-nlCan J Psychiatry 52(10):630-46 (2007) Herrmann N
    132007Pharmacotherapy of Alzheimer disease.



    		+-nlCan J Psychiatry 52(10):620-9 (2007) Seow D
    142007Trials and tribulations of evidence-based medicine: the case of Alzheimer disease therapeutics.



    		+-nlCan J Psychiatry 52(10):617-9 (2007) Herrmann N
    152004GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia.



    		+-nlCan J Psychiatry 49(7):439-53 (2004) Lanctot KL
    162007Changing the course of Alzheimer's disease: anti-amyloid disease-modifying treatments on the horizon.



    		+-nlPrim Care Companion J Clin Psychiatry 9(1):32-41 (2007) Christensen DD
    171999The neurobiology and pharmacotherapy of Alzheimer's disease.



    		+-nlJ Neuropsychiatry Clin Neurosci 11(1):19-31 (1999)
    182000Neurobiological basis of behavioral and psychological symptoms in dementia of the Alzheimer type.



    		+-nlPsychiatry Clin Neurosci 54(6):611-20 (2000)
    192001Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges.



    		+-nlLearn Mem 8(3):121-33 (2001)
    202009Update on the use of memantine in Alzheimer's disease.



    		+-nlNeuropsychiatr Dis Treat 5():237-47 (2009) van Marum RJ
    212008Cost-effectiveness of drug therapies for Alzheimer's disease: A brief review.



    		+-nlNeuropsychiatr Dis Treat 4(3):549-55 (2008) Geldmacher DS
    222007Memantine: efficacy and safety in mild-to-severe Alzheimer's disease.



    		+-nlNeuropsychiatr Dis Treat 3(2):245-58 (2007) Tampi RR
    232007Progress update: Pharmacological treatment of Alzheimer's disease.



    		+-nlNeuropsychiatr Dis Treat 3(5):569-78 (2007) Hogan DB
    242006Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.



    		+-nlNeuron 52(1):15-31 (2006) Small SA
    252006A hundred years of Alzheimer's disease research.



    		+-nlNeuron 52(1):3-13 (2006) Hardy J
    262004Deciphering the molecular basis of memory failure in Alzheimer's disease.



    		+-nlNeuron 44(1):181-93 (2004) Walsh DM
    271996Mechanisms of neuronal degeneration in Alzheimer's disease.



    		+-nlNeuron 16(5):921-32 (1996)
    282009The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.



    		+-nlJ Neurochem 109 Suppl 1():153-9 (2009) Wang X
    292007Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics.



    		+-nlJ Neurochem 103 Suppl 1():171-9 (2007) Han X
    302010Tau oligomers and aggregation in Alzheimer's disease.



    		+-nlJ Neurochem 112(6):1353-67 (2010) Meraz-Rios MA
    312009Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease.



    		+-nlJ Neurochem 111(6):1275-308 (2009) Martins IJ
    322009The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.



    		+-nlJ Neurochem 110(4):1129-34 (2009) Hardy J
    332007Alzheimer's disease: the lipid connection.



    		+-nlJ Neurochem 103 Suppl 1():159-70 (2007) Hartmann T
    342006Alois Alzheimer and Alzheimer's disease: a centennial perspective.



    		+-nlJ Neurochem 99(3):708-10 (2006) Small DH
    352006Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?



    		+-nlJ Neurochem 98(4):993-1006 (2006) Gotz J
    362006Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.



    		+-nlJ Neurochem 97(6):1700-25 (2006) Masters CL
    372006Septal networks: relevance to theta rhythm, epilepsy and Alzheimer's disease.



    		+-nlJ Neurochem 96(3):609-23 (2006) Colom LV
    382006Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.



    		+-nlJ Neurochem 96(1):1-13 (2006) Reddy PH
    392006Neuronal protection by sirtuins in Alzheimer's disease.



    		+-nlJ Neurochem 96(2):305-13 (2006) Anekonda TS
    402004Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.



    		+-nlJ Neurochem 91(3):521-36 (2004) Gasparini L
    412004A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade.



    		+-nlJ Neurochem 91(3):513-20 (2004) Wirths O
    422003Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration.



    		+-nlJ Neurochem 86(6):1313-27 (2003) Butterfield DA
    431999Alzheimer's disease and the amyloid beta protein: What is the role of amyloid?



    		+-nlJ Neurochem 73(2):443-9 (1999)
    441997An etiological role of amyloidogenic carboxyl-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease.



    		+-nlJ Neurochem 68(5):1781-91 (1997)
    452009Mechanism-based treatments for Alzheimer's disease.



    		+-nlDialogues Clin Neurosci 11(2):159-69 (2009) Davies P
    462009Imaging in Alzheimer's disease.



    		+-nlDialogues Clin Neurosci 11(2):191-9 (2009) Scheltens P
    472009Biological markers for early detection and pharmacological treatment of Alzheimer's disease.



    		+-nlDialogues Clin Neurosci 11(2):141-57 (2009) Hampel H
    482009Novel strategies for the prevention of dementia from Alzheimer's disease.



    		+-nlDialogues Clin Neurosci 11(2):129-34 (2009) Shineman DW
    492009Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.



    		+-nlDialogues Clin Neurosci 11(2):111-28 (2009) Qiu C
    502007Frontotemporal dementia to Alzheimer's disease.



    		+-nlDialogues Clin Neurosci 9(2):153-60 (2007) Silveri MC
    512003The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.



    		+-nlCNS Drug Rev 9(3):275-308 (2003) Rogawski MA
    522002Imaging amyloid-beta deposits in vivo.



    		+-nlJ Cereb Blood Flow Metab 22(9):1035-41 (2002)
    532009Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.



    		+-nlJ Clin Neurol 5(4):153-66 (2009) Mistur R
    542007The involvement of astrocytes and kynurenine pathway in Alzheimer's disease.



    		+-nlNeurotox Res 12(4):247-62 (2007) Ting KK
    552007Glial cell dysregulation: a new perspective on Alzheimer disease.



    		+-nlNeurotox Res 12(4):215-32 (2007) von Bernhardi R
    562002Involvement of Maillard reactions in Alzheimer disease.



    		+-nlNeurotox Res 4(3):191-209 (2002) Reddy VP
    572003The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development.



    		+-nlJ Pharmacol Exp Ther 306(3):821-7 (2003) Terry AV Jr
    582009Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection.



    		+-nlPharmacol Rev 61(1):39-61 (2009) Buckingham SD
    592002Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.



    		+-nlPharmacol Rev 54(3):469-525 (2002)
    601997From molecular structure to Alzheimer therapy.



    		+-nlJpn J Pharmacol 74(3):225-41 (1997)
    612006The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.



    		+-nlHealth Technol Assess 10(1):iii-iv, ix-xi, 1-160 (2006) Loveman E
    621999Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity.



    		+-nlJ Leukoc Biol 65(4):416-27 (1999)
    631999Inflammation of the brain in Alzheimer's disease: implications for therapy.



    		+-nlJ Leukoc Biol 65(4):409-15 (1999)
    642008Alzheimer's disease is type 3 diabetes-evidence reviewed.



    		+-nlJ Diabetes Sci Technol 2(6):1101-13 (2008)
    652005Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.



    		+-nlActa Biochim Pol 52(2):417-23 (2005) Kirkitadze MD
    662000Alzheimer's disease: its origin at the membrane, evidence and questions.



    		+-nlActa Biochim Pol 47(3):725-33 (2000)
    672010Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease.



    		+-nlMol Biosyst 6(10):1760-6 (2010) Takeda S
    682009Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease.



    		+-nlMol Biosyst 5(2):134-42 (2009) Bica L
    692001Molecular and cell biological aspects of Alzheimer disease.



    		+-nlJ Hum Genet 46(11):609-18 (2001)
    701996Biological markers for the clinical diagnosis of Alzheimer's disease.



    		+-nlTohoku J Exp Med 179(2):65-79 (1996)
    711994Alzheimer's disease and beta-amyloid.



    		+-nlTohoku J Exp Med 174(3):181-303, A1-3 (1994)
    721994Inflammatory response in Alzheimer's disease.



    		+-nlTohoku J Exp Med 174(3):295-303 (1994)
    732006Alzheimer's disease: psychopathology, medical management and dental implications.



    		+-nlJ Am Dent Assoc 137(9):1240-51 (2006) Friedlander AH
    742005Fatty acid oxidation in the pathogenesis of Alzheimer's disease.



    		+-nlAm J Pathol 166(5):1283-9 (2005) Montine TJ
    751996The Golgi apparatus and the pathogenesis of Alzheimer's disease.



    		+-nlAm J Pathol 148(2):355-60 (1996)
    762007Mitoenergetic failure in Alzheimer disease.



    		+-nlAm J Physiol Cell Physiol 292(1):C8-23 (2007) Parihar MS
    772004Alzheimer disease: mechanistic understanding predicts novel therapies.



    		+-nlAnn Intern Med 140(8):627-38 (2004) Selkoe DJ
    782003Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.



    		+-nlAnn Intern Med 138(5):400-10 (2003) Clark CM
    792008Retromer sorting: a pathogenic pathway in late-onset Alzheimer disease.



    		+-nlArch Neurol 65(3):323-8 (2008) Small SA
    802006Therapeutic approaches to Alzheimer's disease.



    		+-nlBrain 129(Pt 11):2840-55 (2006) Klafki HW
    812009The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.



    		+-nlFolia Neuropathol 47(4):289-99 (2009) Armstrong RA
    822006Plaques and tangles and the pathogenesis of Alzheimer's disease.



    		+-nlFolia Neuropathol 44(1):1-11 (2006) Armstrong RA
    832005The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease.



    		+-nlJ Clin Invest 115(5):1121-9 (2005) Gandy S
    841999The cholinergic hypothesis of Alzheimer's disease: a review of progress.



    		+-nlJ Neurol Neurosurg Psychiatry 66(2):137-47 (1999)
    852004Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.



    		+-nlJ Psychiatry Neurosci 29(6):427-41 (2004) Kar S
    862003Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.



    		+-nlJ Psychiatry Neurosci 28(1):13-26 (2003) Lanctot KL
    872009Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice.



    		+-nlJAMA 302(4):436-7 (2009) Petersen RC
    882003Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.



    		+-nlJAMA 289(2):210-6 (2003) Trinh NH
    892005Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease.



    		+-nlNeuroRx 2(4):612-26 (2005) Jacobsen JS
    902004Biomarkers of Alzheimer disease in plasma.



    		+-nlNeuroRx 1(2):226-34 (2004) Irizarry MC
    912004Cerebrospinal fluid protein biomarkers for Alzheimer's disease.



    		+-nlNeuroRx 1(2):213-25 (2004) Blennow K
    922004Molecular neuroimaging in Alzheimer's disease.



    		+-nlNeuroRx 1(2):206-12 (2004) Jagust W
    932004Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.



    		+-nlNeuroRx 1(2):196-205 (2004) Kantarci K
    942004Neuroprotective strategies in Alzheimer's disease.



    		+-nlNeuroRx 1(1):117-27 (2004) Longo FM
    951992Alzheimer's disease.



    		+-nlPostgrad Med J 68(801):528-32 (1992)
    962002Alzheimer disease as a vascular disorder: nosological evidence.



    		+-nlStroke 33(4):1152-62 (2002)
    972004Alzheimer's disease: neuropathologic findings and recent advances in imaging.



    		+-nlAJR Am J Roentgenol 182(1):3-13 (2004) Norfray JF
    982002Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.



    		+-nlJ Nucl Med 43(8):983-90 (2002)
    992008Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease.



    		+-nlCMAJ 179(12):1279-87 (2008) Herrmann N
    1002003Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.



    		+-nlCMAJ 169(6):557-64 (2003) Lanctot KL
    1012000Causes of Alzheimer's disease.



    		+-nlCMAJ 162(1):65-72 (2000)
    1022009Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis.



    		+-nlAJNR Am J Neuroradiol 30(2):404-10 (2009) Yuan Y
    1032008Neuropathology for the neuroradiologist: plaques and tangles.



    		+-nlAJNR Am J Neuroradiol 29(1):18-22 (2008) Wippold FJ 2nd
    1042010Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.



    		+-nlAge (Dordr) 32(3):365-84 (2010)
    1052011Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.



    		+-nlAlzheimers Res Ther 3(1):1 (2011)
    1062011The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease.



    		+-nlAlzheimers Res Ther 3(3):20 (2011)
    1072010Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy.



    		+-nlAlzheimers Res Ther 2(1):1 (2010)
    1082009Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease.



    		+-nlAlzheimers Res Ther 1(2):7 (2009)
    1092009Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease.



    		+-nlAlzheimers Res Ther 1(2):6 (2009)
    1102009Drug development for Alzheimer's disease: where are we now and where are we headed?



    		+-nlAm J Geriatr Pharmacother 7(3):167-85 (2009)
    1112011[Guidelines for the medical treatment of patients with Alzheimer's disease].



    		+-nlActa Neurol Taiwan 20(2):85-100 (2011)
    1122010Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.



    		+-nlActa Neuropathol 120(3):385-99 (2010)
    1132010The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.



    		+-nlActa Neuropathol 120(2):131-43 (2010)
    1142010Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease.



    		+-nlActa Neuropathol 119(5):523-41 (2010)
    1152011Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.



    		+-nlActa Neuropathol 121(5):571-87 (2011)
    1162008TAR DNA-binding protein-43 in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer disease.



    		+-nlActa Neuropathol 116(2):135-40 (2008)
    1172008Alzheimer disease models and human neuropathology: similarities and differences.



    		+-nlActa Neuropathol 115(1):5-38 (2008)
    1182011Amyloid precursor protein processing and Alzheimer's disease.



    		+-nlAnnu Rev Neurosci 34(-):185-204 (2011)
    1192010Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease.



    		+-nlAJNR Am J Neuroradiol 31(5):847-55 (2010)
    1202011Alzheimer's disease: a review of recent developments.



    		+-nlAnn Afr Med 10(2):73-9 (2011)
    1212008Neurobiology of apathy in Alzheimer's disease.



    		+-nlArq Neuropsiquiatr 66(2B):436-43 (2008)
    1222010Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners.



    		+-nlAltern Med Rev 15(3):223-44 (2010)
    1232008Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.



    		+-nlAltern Med Rev 13(2):85-115 (2008)
    1242004Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up.



    		+-nlAm J Pathol 164(3):757-61 (2004)
    1252009Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease.



    		+-nlAm J Transl Res 1(2):131-47 (2009)
    1262010Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.



    		+-nlBiochim Biophys Acta 1801(8):878-86 (2010)
    1272010Murine models of Alzheimer's disease and their use in developing immunotherapies.



    		+-nlBiochim Biophys Acta 1802(10):847-59 (2010)
    1282010Membrane rafts in Alzheimer's disease beta-amyloid production.



    		+-nlBiochim Biophys Acta 1801(8):860-7 (2010)
    1292010Intracellular cholesterol homeostasis and amyloid precursor protein processing.



    		+-nlBiochim Biophys Acta 1801(8):853-9 (2010)
    1302010Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships?



    		+-nlBiochim Biophys Acta 1801(8):975-82 (2010)
    1312010Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.



    		+-nlBiochim Biophys Acta 1802(1):11-9 (2010)
    1322010Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.



    		+-nlBiochim Biophys Acta 1801(8):924-9 (2010)
    1332007Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm.



    		+-nlBiochim Biophys Acta 1768(8):1966-75 (2007)
    1342007Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis.



    		+-nlBiochim Biophys Acta 1772(4):430-7 (2007)
    1352007Focal adhesions regulate Abeta signaling and cell death in Alzheimer's disease.



    		+-nlBiochim Biophys Acta 1772(4):438-45 (2007)
    1362007Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?



    		+-nlBiochim Biophys Acta 1772(4):422-9 (2007)
    1372009Relevance of transgenic mouse models to human Alzheimer disease.



    		+-nlJ Biol Chem 284(10):6033-7 (2009)
    1382009Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure.



    		+-nlJ Biol Chem 284(10):6027-31 (2009)
    1392010Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy.



    		+-nlDement Geriatr Cogn Disord 30(2):161-78 (2010)
    1402008Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer disease.



    		+-nlDement Geriatr Cogn Disord 26(4):384-90 (2008)
    1412011Modes of Aβ toxicity in Alzheimer's disease.



    		+-nlCell Mol Life Sci 68(20):3359-75 (2011)
    1422010Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process.



    		+-nlPhysiol Rev 90(2):465-94 (2010)
    1432009Reassessing the amyloid cascade hypothesis of Alzheimer's disease.



    		+-nlInt J Biochem Cell Biol 41(6):1261-8 (2009)
    1442004Contribution of cerebral amyloid angiopathy to Alzheimer's disease.



    		+-nlJ Neurol Neurosurg Psychiatry 75(1):1-4 (2004)
    1452007Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review.



    		+-nlJ Neurol Neurosurg Psychiatry 78(9):917-28 (2007)
    1462010Amyloid-independent mechanisms in Alzheimer's disease pathogenesis.



    		+-nlJ Neurosci 30(45):14946-54 (2010)
    1472010Quantitative structural MRI for early detection of Alzheimer's disease.



    		+-nlExpert Rev Neurother 10(11):1675-88 (2010)
    1482010Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.



    		+-nlExpert Rev Neurother 10(5):683-91 (2010)
    1492004Donepezil (Aricept) for treatment of Alzheimer's disease and other dementing conditions.



    		+-nlExpert Rev Neurother 4(1):5-16 (2004)
    1502008Gamma-secretase modulators: hopes and setbacks for the future of Alzheimer's treatment.



    		+-nlExpert Rev Neurother 8(11):1611-3 (2008)
    1512008Targeting miRNAs in Alzheimer's disease.



    		+-nlExpert Rev Neurother 8(11):1615-6 (2008)
    1522008Cystatin C: a potential target for Alzheimer's treatment.



    		+-nlExpert Rev Neurother 8(5):687-9 (2008)
    1532009All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease.



    		+-nlExpert Rev Neurother 9(11):1615-21 (2009)
    1542010The biochemical study on the etiology of Alzheimer's disease.



    		+-nlProc Jpn Acad Ser B Phys Biol Sci 86(1):54-61 (2010)
    1552010Current status on Alzheimer disease molecular genetics: from past, to present, to future.



    		+-nlHum Mol Genet 19(R1):R4-R11 (2010)
    1562010Molecular mechanisms of neurodegeneration in Alzheimer's disease.



    		+-nlHum Mol Genet 19(R1):R12-20 (2010)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.